Data analytics in the past decade has proven to be a breakthrough for various applications of data science to enhance profits and to win over competition. Industries such as healthcare, banking and finance have harnessed data to identify new opportunities thereby creating successful commercial case studies which allow experts to take the right decisions at the right time to achieve maximum return on investments and efficient operations.
In a constantly evolving innovative time, companies continue to wrestle for deriving more value from their “business and corporate strategies”. The significance of a business strategy relies on it being a viable way to build up business desires, creating a competitive advantage and additionally increment shareholder value to something beyond the aggregate of its physical resources. MarketsandMarkets Chief Strategy Officer Forum invites leading strategy decision makers who are making the future.
The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised and accurate.
In the era of improved diagnostics, our inaugural MarketsandMarkets Advanced Diagnostics Series that is scheduled to be held on 5-6 October, 2020, in London - UK, will serve as a networking place for Diagnostics professional, Industrial specialists, and solution providers to address the rising innovation in its discipline and the way it can be used as disease prevention tool.
MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on October 22-23, 2020 in Boston, USA.
While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.
Click here to see the post-show report of our 2nd Edition of the congress.
Around 1 in 20 (6%) of patients are affected by preventable harm in medical care, of which around 12% causes permanent disability or death, according to a study published by The BMJ. These infections are contracted by an estimated 1.7 million patients annually and responsible for 99,000 deaths each year.
Preventing disease and controlling spread of resistant bacteria is of major importance when tackling antibiotic resistance. Already, AMR infections are estimated to cause 700,000 deaths each year globally, which is predicted to rise to 10 million, alongside a cumulative cost of $100 trillion, by 2020 if no action is taken.
In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.
Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.
Where does your success begin? With constant development emerging in global marketing scenario, things have become far more complicated then it seems. Smarter marketing solutions opted by the Chief Marketing professionals give the holistic view over the depth of any industry, economically and ideologically. These solutions help organizations improve their measurement and strategic planning. Smarter the solutions, better the outcomes.
The world health is taking a new leap and is being re-structured with multiple technological pillars viz MedTech, Robotic surgery, Artificial Intelligence, TeleHealth, IoMT, Blockchain adding on to many more. Get addressed to challenges like remote patient monitoring, data management, long gestation period, new technology adaption & tedious regulatory hurdles by applying these technologies to make things easier.